Infectious Diseases

Verrica received a Complete Response Letter from the FDA regarding their New Drug Application for the topical molluscum contagiosum treatment, VP-102.

Pfizer-BioNTech reports strong immune response, high efficacy, and favorable safety in third dose of the COVID-19 vaccine.

Research suggests that COVID-19 vaccination may serve a therapeutic effect, possibly reducing the risk of developing long COVID when administered to those currently infected.

A look at what the Contemporary Pediatrics® team covered this week.

Tina Tan, MD, FAAP, FIDSA, FPIDS, editor-in-chief of Contemporary Pediatrics, shares her insights on the recent outbreaks of hepatitis in children.

New data suggest pediatric patients with a history of cardiac arrest are highly susceptible to hospitalization if infected with SARS-CoV-2.

Nearly 9 million symptomatic cases also avoided.

Contemporary Pediatrics® Editorial Advisory Board member Donna Hallas shares her thoughts on the recent authorization of a Pfizer-BioNTech COVID-19 booster shot for children 5-11 years old.

A comparison of COVID-19 PCR tests and rapid self-tests found self-tests to be highly accurate and user-friendly for children.

Children may receive a single booster shot at least 5 months after completing their initial Pfizer-BioNTech 2-dose series.

Active immunization of pregnant women with investigational vaccine protected infants from RSV from birth through at least 6 months.

Children living with HIV had a similar immune response to mRNA COVID-19 vaccination as children without HIV.

What are the unique challenges for individuals with ADHD?

The higher the gestational age when pregnant women received a COVID-19 vaccine, the higher the serological titers at birth.

What infections besides COVID-19 should be on pediatric health care providers’ radar?

An investigation offers more evidence that shorter antibiotic courses can be just as effective as longer ones.

A look at a recently presented study on improving 23-valent pneumococcal polysaccharide vaccine uptake in groups that are at high risk.

The study finds large drops in life expectancy for Hispanic and Black people in 2020.

The pandemic underscored the incredible power of vaccination.

Lawmakers want to expand telehealth options for children, cognitive research.

Pfizer/BioNTech announce positive results for a third dose of their COVID-19 vaccine for children

Poll respondents ‘hesitant,’ ‘resistant’ to get Pfizer-BioNTech shots

An 18-day-old girl whose right cheek had become increasingly red and warm over 24 hours was directly admitted to an inpatient unit. She had firmness and pain to the affected area, fussiness, increased sleeping, and poor feeding, preferring the bottle to breastfeeding. What's the diagnosis?

Wastage data published for first two months of 2021.

William J. Muller, MD, PhD, discusses COVID-19 vaccinations for children and what is on the horizon for a potential RSV vaccine.

We seek to reduce vaccine side effects—but what about the social media-compounded fears of anti-COVID vaccination?

A study examined 4 million posts on social media site in 2021.

Was the spike in pediatric cases during the Delta wave of COVID-19 linked to an increase in severe illness? A report offers some answers.

A look at the way that skin may react to COVID-19 and the vaccine for the disease.